05:40 AM EDT, 05/14/2024 (MT Newswires) -- Cue Health ( HLTH ) said late Monday it is evaluating a warning letter it received from the US Food and Drug Administration regarding its Emergency Use Authorized COVID-19 test.

"The [c]ompany is currently evaluating the letter and determining its response, with more information to follow in the next few days," the company said.

Price: 0.1299, Change: +0.01, Percent Change: +6.30